Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Ranbaxy Laboratories is in a free fall, there is nothing to hold it. There is no support because the support comes in when there are buyers in the market, there are no buyers here. We just let it go."
"Two things - first the smallest rally is a selling opportunity in Ranbaxy and second we would not even dream of buying or catching falling knives," Sukhani said. Also Read: Ranbaxy slumps on Mohali plant under USFDA watch reports
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
